| Date | Form | Description | Docs | XBRL | Pages |
| 05/17/17 | 8-K | Current report filing |
|
30 | |
| 05/15/17 | 424B2 | Prospectus filed pursuant to Rule 424(b)(2) |
|
51 | |
| 05/11/17 | 424B2 | Prospectus filed pursuant to Rule 424(b)(2) |
|
51 | |
| 04/13/17 | 8-K | Current report filing |
|
3 | |
| 04/10/17 | EFFECT | Notice of Effectiveness |
|
1 | |
| 04/06/17 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 04/05/17 | 8-K | Current report filing |
|
4 | |
| 04/04/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/03/17 | UPLOAD | SEC-generated letter |
|
1 | |
| 03/31/17 | S-3 | Registration statement for specified transactions by certain issuers |
|
50 |
Latest News & Events
Anixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
Read More...Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Read More...Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology
Read More...